Answer
Finerenone should not be initiated in patients with severe hepatic impairment because these patients have not been studied and a significant increase in finerenone exposure is expected.
Sources for this answer
- Kerendia 10 mg film coated tabletsBayer plc · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked